Cancer Specialists of North Florida - Riverside

Jacksonville, FL

Sorting 3 by

Accepting patients

Ruxolitinib

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Learn more
  • Kinase Inhibitor
  • Phase 1
  • Has results

Accepting patients

TRIlogy-3

A Phase 2, Open-label Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Who Have Received at Least 3 Prior Lines of Therapy Including a PI, an IMiD, and an Anti-CD38 Antibody
Learn more
  • Trispecific Antibody
  • GPRC5D
  • BCMA
  • Phase 2

Accepting patients

HLX15-SC

A Randomized, Double-blind, Parallel-controlled Phase I Study to Compare the Pharmacokinetic Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Learn more
  • Monoclonal Antibody
  • CD38
  • Randomization
  • Closed Label (Masked)
  • Phase 1